Plain-English translation of NCT06174103 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is an early feasibility study of the BiVACOR Total Artificial Heart (TAH) System, a mechanical pump designed to take over the work of a failing heart. The trial is testing whether this artificial heart can safely help adults with very severe heart failure on both sides of the heart stay alive while they wait for a donor heart transplant. Only about 5 patients will be enrolled in this very early phase of testing.
Some patients have heart failure so severe that their right side of the heart fails along with the left side, and standard devices (which support only one side) won't help them. This trial exists to see whether an artificial heart that replaces both sides can keep these critically ill patients alive until a transplant becomes available.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo surgery to have the BiVACOR artificial heart implanted to replace your failing heart. After implantation, you will remain hospitalized while researchers monitor how well the device works, how your body responds, and whether it safely supports you while you wait for a heart transplant. The study will closely track your health, heart function, and any side effects throughout your time with the device.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States